CD274 and head and neck squamous cell carcinoma: As common chemotherapeutic drugs for HNSCC, they are also supposed to exhibit a similar synergistic effect with PD-1/PD-L1 blockade in HNSCC, but further clinical analysis still needs to be carried out.